Key Highlights
- Mendaera closes $73M Series B funding led by Threshold Ventures, with investors including Lux Capital and PFM Health Sciences.
- Developing handheld robotic platform combining robotics, AI, and real-time imaging for needle-based medical procedures.
- Addresses healthcare labor shortages and rising costs through scalable robotic solutions.
- Partnership with Butterfly Network and acquisition of Avail Medsystems expands platform capabilities.
Source: Business Wire
Notable Quotes
- “Robotics and AI have evolved to a point where we can deliver broader benefits across all parts of the healthcare system and enable higher standards of care for more patients.” — Josh DeFonzo, Founder and CEO at Mendaera
- “Amidst rising healthcare costs and labor shortages impacting quality and affordability, it is imperative to harness advanced technology to revolutionize healthcare delivery. We are thrilled to join forces with the dynamic Mendaera team, comprising the most innovative and accomplished leaders in medical robotics and software.” — Emily Melton, Managing Partner at Threshold Ventures
SoHC's Take
Mendaera’s successful $73M Series B round marks a pivotal moment in medical technology, pushing the boundaries of robotics beyond high-end surgical applications into everyday procedures like biopsies and vascular access. With the convergence of robotics, AI, and virtual connectivity, Mendaera is uniquely positioned to alleviate the healthcare system’s growing burdens of rising costs and labor shortages. This innovative platform has the potential to drastically improve accessibility and efficiency in needle-based procedures, offering an adaptable solution that could standardize care across specialties, driving down costs while elevating the quality of patient outcomes.
